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SUMMARY
Introduction This is a presentation of a 61-year-old female patient. Since 44 years have passed from the 
onset of her first symptoms until the final diagnosis of sarcoidosis, this was the reason of our decision 
to publish the case.
Case Outline During the follow-up period of 44 years the patient had ocassional polymorphic complains, 
such as adynamia, nausea, abdominal pains, myalgia, arthralgia, body weight loss (8-10 kg) etc. The 
clinical course was predominated by splenomegaly, hepatitis and arthralgia, and later chronic renal failure 
also developed. Laboratory findings showed elevated markers of acute inflammation and autoantibodies. 
The patient was hospitalized in different university internal hospitals (gastroenterology, allergology, 
rheumatology, nephrology and pulmology). Liver biopsy was performed three times, rectum and kidney 
biopsy once each and finally bronchoscopy and pulmonary biopsy was done. At last, about 40 years from 
the onset of the first symptoms, in 2006 the diagnosis of lung sarcoidosis was established.
Conclusion The final diagnosis of spleen sarcoidosis was confirmed by pathologically verified sarcoidosis 
of the lungs. This case is particularly interesting because of the presence of familial sarcoidosis (the 
patient’s son also had recurrent pulmonary sarcoidosis).
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INTRODUCTION
Sarcoidosis is a chronic granulomatous disease 
of unknown origin, with pulmonary involve-
ment in more than 90% of patients. Sometimes 
sarcoidosis can be an enigmatic disease with 
extremely variable manifestations in pattern, 
severity and course [1, 2, 3]. Abdominal sar-
coidosis is a rare manifestation with the in-
volvement of the liver, spleen or kidney. It 
can be also commonly underestimated thus 
causing unnecessary diagnostic dilemma. The 
diagnosis of spleen sarcoidosis may become a 
complex clinical problem, because differential 
diagnosis varies between hematological dis-
orders or disseminated infectious or tropical 
diseases and other multisystemic diseases with 
spleen involvement [4, 5, 6]. The final diagnosis 
of abdominal sarcoidosis can be passed when 
there is a pathological diagnosis of other organ 
involvement and clinical or radiological symp-
toms or signs consistent with liver or spleen 
involvement [7].
CASE REPORT
In 1967, when aged 17 years, our patient ex-
perienced sudden abdominal pains, followed 
by general feeling of weakness and malaise. 
Clinical and abdominal examination at that 
time showed liver and spleen enlargement, 
with signs of hepatitis of unknown etiology; 
detailed immunological data from that time are 
missing. During the first three years the patient 
was treated at a regional hospital. Symptomatic 
therapy included lower doses of corticosteroids 
(10 mg per day) and did not lead to significant 
improvement. In 1973, she delivered a healthy 
boy, with a complete illness remission dur-
ing pregnancy. Liver biopsies were performed 
twice (1975, 1976) due to pain in the right up-
per abdomen (pathology: hepatic fibrosis and 
chronic fibrous pericholangiolitis). There was 
no suspicion of liver sarcoidosis or elements 
of granulomatous inflammation. There was a 
suspicion of liver fibrosis. After that, rectal bi-
opsy was done (pathology: chronic interstitial 
colitis). In 1976, during abdominal laparos-
copy due to polypectomy, splenomegalia was 
seen although the patient was asymptomatic. 
In 1987, ultrasonography of liver detected a 
diffuse nonhomogenic and modestly enlarged 
spleen with lymph nodes in the splenic hilum 
of about 25 mm in size. For the first time labo-
ratory findings of high gamma globulin values, 
positive antimitochondrial antibodies (AMA) 
and smooth-muscle antibodies (SMA) were es-
tablished along with non-specific markers of 
inflammation. At this period, corticosteroids 
(15 mg/day) were administered several times 
during 1-2 years due to a suspected systemic      
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disease of the connective tissue. Therefore the patient was 
referred to the Department of Rheumatology for further 
investigation. In 1991 splenomegaly and chronic hepatitis 
were detected again. During 1993 the patient developed 
arterial hypertension and kidney failure (glomerular fil-
tration rate – GFR 50-60 ml/min) and proteinuria (0.5-1 
g/24 h). In 1997 clinical and laboratory signs of different 
systemic disease persisted. The criteria for systemic lu-
pus erythematosus were not met, however non-specific 
markers of inflammation and autoantibodies were de-
tected (FITC ANA 0, anti-DNK antibodies 0). Kidney 
biopsy was performed (pathologic analysis showed a few 
glomeruli only, with a thickened basal membrane, but with 
predominant tubulointerstitial fibrosis and sclerosis with 
vascular sclerosis). During the next two years, the patient 
was treated with azathioprine (75 mg) and corticoids (5-20 
mg/day). In 2000, she was on corticosteroid therapy due 
to renal failure. First detected changes of the chest were 
interpreted as interstitial fibrosis, but it was not further 
investigated. The spleen and hepatogram were normal and 
only gamma globins were slightly elevated. In 2006, wors-
ening of kidney function was detected (rising serum cre-
atinine level up to 170 µmol/L and declining GFR of less 
than 40 ml/min). Kidney ultrasound revealed small sized 
kidneys with thin and bright renal parenchyma (features 
of chronic kidney disease). Since she had fever, chest CT 
was done revealing bilateral lymph node enlargement with 
interstitial changes (Figure 1). This time a pulmologist was 
consulted and bronchoscopy was indicated. Bronhoscopy 
revealed hyperemic mucosa covered with white nodules. 
Pathological analysis discovered epithelioid noncaseating 
granuloma verisimilar sarcoidosis (Figure 2). Also, the val-
ue of angiotensin-converting enzyme (60.2 U/L) and cal-
cium serum level (2.85 mmol/l) were elevated. Meanwhile, 
hepatogram and ultrasound liver and spleen findings were 
normal. The diagnosis of pulmonary sarcoidosis grade I/
II was established. In the meantime, the patient’s son aged 
28 years was prior to our patient diagnosed pulmonary 
sarcoidosis. Since 2006 corticoid therapy (at initial dose 
of 30 mg/day) was decreased and excluded during 2008. 
Throughout the first 6 months in 2009, the patient was 
feeling well. Corticosteroids were withdrawn because chest 
and abdominal computerized tomography (CT) findings 
and ACE level were normal. However, in the second part 
of 2009 she started to loose on weight (over 10 kg) and 
had nausea, and abdominal pains. Due to these complaints 
and renal failure progression the patient was admitted at 
Nephrology Clinic in January 2010. Abdominal CT re-
vealed enlarged spleen with diffuse hypodense nodules 
(Figure 3) and chest CT showed a bilateral pulmonary re-
ticulonodular pattern with mediastinal lymphadenopathy. 
For the first time ACE level was increased (up to 99 U/L) 
and polyclonal hypergammaglobulinemia was revealed 
(particularly IgG and IgA). Bone marrow biopsy was 
performed and findings were negative for neoplasia/lym-
phoma. Tumor markers were also negative and infections 
were excluded. During this time dermatology examina-
tion of the skin revealed changes typical of skin sarcoidosis 
(papular erythema with minimal whitish squamosis of the 
hands and legs). Thus, according to chest and abdominal 
CT, high ACE level, skin changes and other examinations, 
the diagnosis of pulmonary and extrapulmonary sarcoid-
osis recurrence was established. Prednisolone (30 mg/day) 
therapy was started again in March 2010. Follow-up of 
the patient in June and September 2010 revealed improve-
ment of subjective feeling, without prior symptoms during   
Figure 1. Chest CT scan shows thickened interstitium of both lungs 
and enlarged hilar lymph nodes
Figure 3. Coronary reformatted abdominal CT revealed enlarged sple-
en with numerous hypodense nodular lesions (arrows)
Figure 2. Microphotograph of lymph node shows epithelioid nonca-
seating granuloma  
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prednisolone in dose of 10-20 mg/day and renal insuffi-
ciency which stabilized (creatinine clearance 40 ml/min). 
Chest and abdominal CT showed absence of lymphade-
nopathy and hepatosplenomegaly (Figure 4). Laboratory 
analysis showed that ACE level was within normal limits. 
On the last follow-up the patient was without pulmonary 
and spleen sarcoidosis.
DISCUSSION
In patients with splenic sarcoidosis the disease is usually 
severe, persistent and chronic, and tends to affect extra-
thoracic organs [8, 9, 10]. At the time when our patient ex-
perienced first signs and symptoms of splenic sarcoidosis 
almost 40 years ago, diagnostic procedures for sarcoidosis 
were developing. This case report confirms the rule that 
the diagnosis of sarcoidosis is more accurate when it is 
suspected by the doctor. Extrapulmonary presentation as 
the initial manifestation of the disease is often unrecog-
nized and may mimic other etiologies. Therefore, in this 
patient the diagnosis of sarcoidosis remained an unsolved 
puzzle for over 40 years. The acute onset of the disease, 
with clinical manifestations of splenomegaly and hepati-
tis, were significant prognostic parameters of the chronic 
nature of the disease in our case, as well as the indicated 
results by other investigators [5, 11]. At that time, during 
the 70-ies similar examples were found in the literature 
when splenectomy was performed because of suspected 
lymphoma but later pathological finding revealed sarcoid-
osis [12, 13, 14]. It is well known that corticosteroids are 
indicated as a very effective therapeutic agent at the clini-
cal course of “disease with no name”. Possibly, temporary 
doses of prednisolone in the dose of 5-20 mg were not 
sufficient to stop this chronic inflammatory disease and 
besides, there were permanently appearing new problems. 
Thus, in our case splenomegaly was established for the 
first time in 1976 during laparoscopy, but also in 1987, 
1991 and 2010 by ultrasound or CT examination and at 
that time, according to the medical data, corticosteroid 
therapy was started many times with different durations 
(1-2 years). Spontaneous remissions of sarcoidosis occur 
in nearly two thirds of patients, but chronic, progressive 
disease may result in severe sequelae [4, 5, 10]. This could 
probably be the explanation for the undefined liver find-
ings. Three times repeated liver biopsies pointed to fibro-
sis in a systemic disease or suspected liver TBC because 
of granuloma detection. Laboratory findings suggested 
spreading of the disease to the kidneys, furthermore bi-
opsy of kidneys confirmed interstitial nephritis without 
granulomas, which was also found by Mahévas M. et al. 
[15] in 10 of 43 examined patients. Therapy with azathio-
prine and corticosteroids during the next two years did 
not stop the progression of chronic renal failure but the 
progression was relatively slow during the next 10 years, 
with proteinuria as can be expected in chronic mainly 
tubulointerstitial processes. During 2006, when cortico-
steroid therapy was stopped, radiological, bronchoscopy 
and pulmonary changes appeared which was typical of 
sarcoidosis. For the first time, after a lymph node biopsy 
epithelioid non-caseinating granuloma verisimilar sar-
coidosis was established. On corticoid therapy a complete 
remission was achieved. After long time (1991-2009) the 
patient was without splenomegaly but in 2010, the disease 
reactivated with enlarged spleen and diffuse hypodense 
nodules; a rare form of spleen sarcoidosis seen on abdomi-
nal CT that was previously reported in the literature [16]. 
Chest CT and high level of ACE confirmed reactivation of   
sarcoidosis.
At the end it is very important to note that during a 
long-term follow-up period there was no development of 
hypersplenism, anemia or elevated transaminases. Only 
once, hypercalcemia was detected, but calciuria was not 
measured because GFR was less than 60 ml/min. All the 
time the high sedimentation rate as well as hypergama-
globulinemia was presented as signs of nonspecific inflam-
mation. Finally, after 5 months of corticosteroid therapy 
the patient was again in a complete remission. Also, this 
case is interesting because of the presence of sarcoidosis in 
the patient’s family (patient’s son also had recurrent pul-
monary sarcoidosis). It is possible that genetic factors and 
environmental agents of infection may result in autoim-
mune response that is manifested as sarcoidosis [17]. But 
it is also likely that genetic factors may be important in 
defining the pattern of disease presentation and progres-
sion as well as its overall prognosis. In conclusion, clinical 
manifestations of sarcoidosis, especially abdominal local-
ization are extremely heterogeneous and overlap with a 
wide spectrum of diseases, and due to this fact biopsy 
and pathologic confirmation of sarcoidosis is a necessity 
whenever possible. Final diagnosis of spleen sarcoidosis 
can be confirmed in the presence of pathologically verified 
sarcoidosis of the lungs as in our case.
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Figure 4. Contrast enhanced abdominal CT after treatment demon-
strates spleen of normal size and structure     
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КРАТАК САДРЖАЈ
Увод Ово је при  каз бо  ле  сни  це ста  ре 61 го  ди  ну. С об  зи  ром 
на то да су од пр  вих симп  то  ма бо  ле  сти до ко  нач  не ди  јаг  но-
зе сар  ко  и  до  зе про  шле 44 го  ди  не, то је био раз  лог да овај 
слу  чај об  ја  ви  мо.
При  каз бо  ле  сни  ка То  ком на  ве  де  ног пе  ри  о  да с вре  ме  на на 
вре  ме су се ја  вља  ле по  ли  морф  не те  го  бе, као што су ади  на-
ми  ја, муч  ни  на, бол у тр  бу  ху, ар  трал  ги  ја, ми  ал  ги  ја, гу  би  так 
те  ле  сне те  жи  не (8–10 kg) итд. У кли  нич  кој сли  ци до  ми  ни-
ра  ли су спле  но  ме  га  ли  ја, хе  па  ти  тис и ар  трал  ги  ја, а ка  сни  је 
се раз  ви  ла и хро  нич  на ин  су  фи  ци  јен  ци  ја бу  бре  га. У ла  бо  ра-
то  риј  ским ана  ли  за  ма мар  ке  ри ин  фла  ма  ци  је и ауто  ан  ти  те  ла 
би  ли су по  ви  ше  ни. Бо  ле  сни  ца је би  ла хо  спи  та  ли  зо  ва  на у 
раз  ли  чи  тим ин  тер  ни  стич  ким кли  ни  ка  ма (га  стро  ен  те  ро  ло-
ги  ја, алер  го  ло  ги  ја, ре  у  ма  то  ло  ги  ја, не  фро  ло  ги  ја, пул  мо  ло-
ги  ја). Би  оп  си  ја је  тре је ура  ђе  на три пу  та, би  оп  си  ја бу  бре  га 
и рек  ту  ма јед ном и на кра  ју су ура  ђе  не брон хо  ско  пи  ја и 
би  оп  си  ја плу  ћа. Ко  нач  но, че  тр  де  сет го  ди  на на  кон по  чет  ка 
пр  вих симп  то  ма бо  ле  сти, 2006. го  ди  не је по  твр  ђе  на ди  јаг-
но  за сар  ко  и  до  зе плу  ћа.
За  кљу  чак Ко  нач  на ди  јаг  но  за сар  ко  и  до  зе сле  зи  не по  ста-
вље  на је по  сле па  то  хи  сто  ло  шке по  твр  де сар  ко  и  до  зе плу  ћа. 
Овај слу  чај је по  себ  но за  ни  мљив због по  сто  ја  ња фа  ми  ли  јар-
не сар  ко  и  до  зе (син бо  ле  сни  це је та  ко  ђе бо  ло  вао од ре  ци-
ди  ви  ра  ју  ће сар  ко  и  до  зе плу  ћа).
Кључ  не ре  чи: сар  ко  и  до  за; је  тра; сле  зи  на; плу  ћа; бу  брег
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